Keywords: |
cancer chemotherapy; cancer survival; aged; middle aged; clinical trial; salvage therapy; placebo; multimodality cancer therapy; united states; conference paper; adjuvant therapy; cancer radiotherapy; chemotherapy, adjuvant; radiotherapy, adjuvant; cancer staging; antineoplastic agent; clinical practice; treatment indication; breast cancer; mastectomy; aromatase inhibitor; nccn clinical practice guidelines; practice guideline; age factors; breast neoplasms; age; exemestane; adjuvant chemotherapy; breast tumor; partial mastectomy; medical society; micrometastasis; brachytherapy; tamoxifen; radiation therapy; hormonal therapy; letrozole; antineoplastic agents, hormonal; anastrozole; menopause; antineoplastic hormone agonists and antagonists; practice guidelines
|